Dr. Kimberly Bruneau Petersen, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 33296 Lone Pine Dr, Browerville, MN 56438 Phone: 708-341-1891 |
News Archive
Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has increased and subsequently closed the non-brokered private placement previously announced on August 19, 2009.
Bayer HealthCare (Bayer) and the German Cancer Research Center (DKFZ) will extend their successful strategic research alliance in search of novel cancer therapeutics by focusing their activities also on the field of immunotherapy. Immunotherapies are a promising approach to treat cancer with the aim to selectively reactivate the body's own immune system so that it attacks tumor cells.
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
A small molecule of a drug has been successfully used to treat an inherited form of hearing loss in laboratory mice.
› Verified 2 days ago